EAN 2016

Defining blood biomarkers to modify the diagnostic pathway of dementia

Clinical methods for the psychiatric evaluation of dementia

Diagnostic challenges of dementia in clinical practice

Clinical development of novel pharmacological treatments for Alzheimer’s disease

New approaches for developing disease modifying therapies in Alzheimer’s disease

Ginkgo biloba extract EGb 761® for cognitive impairment: clinical data

Ethical considerations of biomarker use in prodromal Alzheimer’s disease

The landscape of biomarkers for the management of Alzheimer’s disease

Task force from Geneva: Roadmap for biomarker validation in Alzheimer’s disease

The clinical role of MRI in dementia

Emphasizing prevention strategies for the management of dementia

Overview of behavioral and psychological symptoms of dementia

Clinical features of focal dementias

Current approaches for the management of Alzheimer’s disease

Prevention strategies for Alzheimer’s disease

Declining dementia incidence